A significant shift in Canadian drug policy has happened, as the regulators allow the legalization of psilocybin hallucinogens for therapeutic treatment. Until now, these substances were severely restricted, but a mounting body of research suggests they potentially offer relief for psychological conditions like depression. This change represents a